Published in Med Phys on November 01, 2009
Comparison of Head Scatter Factor for 6MV and 10MV flattened (FB) and Unflattened (FFF) Photon Beam using indigenously Designed Columnar Mini Phantom. J Med Phys (2014) 0.79
Quantitative analysis of in-air output ratio. J Radiat Res (2013) 0.79
Measurement and comparison of head scatter factor for 7 MV unflattened (FFF) and 6 MV flattened photon beam using indigenously designed columnar mini phantom. Rep Pract Oncol Radiother (2015) 0.77
Evaluation of beam hardening and photon scatter by brass compensator for IMRT. J Radiat Res (2012) 0.75
An Analytical Method to Calculate Phantom Scatter Factor for Photon Beam Accelerators. Electron Physician (2017) 0.75
IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys (2009) 4.47
Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys (2003) 3.14
Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys (2004) 2.98
Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys (2010) 2.94
Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys (2010) 2.69
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance. Int J Radiat Oncol Biol Phys (2012) 2.55
How low is the alpha/beta ratio for prostate cancer? Int J Radiat Oncol Biol Phys (2003) 2.46
Radiation-associated liver injury. Int J Radiat Oncol Biol Phys (2010) 2.39
Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol (2004) 2.15
Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys (2005) 2.14
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy (2012) 2.11
Small fields: nonequilibrium radiation dosimetry. Med Phys (2008) 2.10
The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys (2002) 2.09
Accelerator beam data commissioning equipment and procedures: report of the TG-106 of the Therapy Physics Committee of the AAPM. Med Phys (2008) 1.89
Image-guided radiotherapy: rationale, benefits, and limitations. Lancet Oncol (2006) 1.86
Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys (2003) 1.78
Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys (2010) 1.74
Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys (2007) 1.72
Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. Phys Med Biol (2004) 1.63
Patient dose from kilovoltage cone beam computed tomography imaging in radiation therapy. Med Phys (2006) 1.62
Identification of a bone marrow-derived CD8αα+ dendritic cell-like population in inflamed autoimmune target tissue with capability of inducing T cell apoptosis. J Leukoc Biol (2010) 1.61
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy (2012) 1.57
Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys (2007) 1.46
Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys (2003) 1.45
Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology". Int J Radiat Oncol Biol Phys (2008) 1.44
Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol (2006) 1.42
Monte Carlo calculated microdosimetric spread for cell nucleus-sized targets exposed to brachytherapy 125I and 192Ir sources and 60Co cell irradiation. Phys Med Biol (2013) 1.41
Measurements of the dosimetric constants for a new 103Pd brachytherapy source. Brachytherapy (2002) 1.40
Tools for consensus analysis of experts' contours for radiotherapy structure definitions. Radiother Oncol (2010) 1.36
Dose specification and quality assurance of radiation therapy oncology group protocol 95-17; a cooperative group study of iridium-192 breast implants as sole therapy. Int J Radiat Oncol Biol Phys (2007) 1.33
Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.32
Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys (2003) 1.31
Quality assurance for computed-tomography simulators and the computed-tomography-simulation process: report of the AAPM Radiation Therapy Committee Task Group No. 66. Med Phys (2003) 1.30
Third-party brachytherapy source calibrations and physicist responsibilities: report of the AAPM Low Energy Brachytherapy Source Calibration Working Group. Med Phys (2008) 1.29
Credentialing of institutions for IMRT in clinical trials. Int J Radiat Oncol Biol Phys (2004) 1.26
Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys (2009) 1.25
Renin-Angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol Biol Phys (2009) 1.25
A method for evaluating quality assurance needs in radiation therapy. Int J Radiat Oncol Biol Phys (2008) 1.22
Evaluation of a commercial biologically based IMRT treatment planning system. Med Phys (2008) 1.22
Validation of dynamic MLC-controller log files using a two-dimensional diode array. Med Phys (2003) 1.19
Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study. Int J Radiat Oncol Biol Phys (2004) 1.19
Impact of breathing motion on whole breast radiotherapy: a dosimetric analysis using active breathing control. Int J Radiat Oncol Biol Phys (2004) 1.18
The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys (2006) 1.18
Initial clinical experience with moderate deep-inspiration breath hold using an active breathing control device in the treatment of patients with left-sided breast cancer using external beam radiation therapy. Int J Radiat Oncol Biol Phys (2003) 1.15
Measuring output factors of small fields formed by collimator jaws and multileaf collimator using plastic scintillation detectors. Med Phys (2010) 1.15
Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma. Cancer (2013) 1.14
Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs. Med Phys (2003) 1.14
Direct aperture optimization-based intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys (2007) 1.14
Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys (2006) 1.13
Clinical implementation of intensity-modulated arc therapy. Int J Radiat Oncol Biol Phys (2002) 1.10
Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in Stereotactic Lung Radiation Therapy. Acta Oncol (2006) 1.10
A new metric for assessing IMRT modulation complexity and plan deliverability. Med Phys (2010) 1.09
Respiratory organ motion and dosimetric impact on breast and nodal irradiation. Int J Radiat Oncol Biol Phys (2010) 1.08
Role of the angiotensin II type-2 receptor in radiation nephropathy. Transl Res (2007) 1.07
Predicting changes in dose distribution to tumor and normal tissue when correcting for heterogeneity in radiotherapy for lung cancer. Am J Clin Oncol (2007) 1.06
TG-69: radiographic film for megavoltage beam dosimetry. Med Phys (2007) 1.06
Online planning and delivery technique for radiotherapy of spinal metastases using cone-beam CT: image quality and system performance. Int J Radiat Oncol Biol Phys (2007) 1.05
Is α/β for breast cancer really low? Radiother Oncol (2011) 1.03
Feasibility of a novel deformable image registration technique to facilitate classification, targeting, and monitoring of tumor and normal tissue. Int J Radiat Oncol Biol Phys (2006) 1.02
Cone beam computed tomography guidance for setup of patients receiving accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2007) 1.02
Re-irradiation of head and neck carcinoma. Am J Clin Oncol (2008) 1.01
A dose comparison study between XVI and OBI CBCT systems. Med Phys (2008) 1.01
Measuring interfractional and intrafractional motion with cone beam computed tomography and an optical localization system for lower extremity soft tissue sarcoma patients treated with preoperative intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.01
Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.00
An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications. Cancers (Basel) (2012) 1.00
Verification of monitor unit calculations for non-IMRT clinical radiotherapy: report of AAPM Task Group 114. Med Phys (2011) 1.00
Cardiac injury after 10 gy total body irradiation: indirect role of effects on abdominal organs. Radiat Res (2013) 0.99
A beam source model for scanned proton beams. Phys Med Biol (2007) 0.98
Intra- and interfractional variations for prone breast irradiation: an indication for image-guided radiotherapy. Int J Radiat Oncol Biol Phys (2007) 0.98
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy (2012) 0.98
Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma. Med Phys (2004) 0.98
A fourier analysis of the dose grid resolution required for accurate IMRT fluence map optimization. Med Phys (2005) 0.98
Clinical evaluation of multi-atlas based segmentation of lymph node regions in head and neck and prostate cancer patients. Radiat Oncol (2013) 0.98
Dosimetric impact of intrafraction motion for compensator-based proton therapy of lung cancer. Phys Med Biol (2008) 0.98
The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us? Int J Radiat Oncol Biol Phys (2003) 0.97
Irradiation of varying volumes of rat lung to same mean lung dose: a little to a lot or a lot to a little? Int J Radiat Oncol Biol Phys (2008) 0.97
Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy. Med Dosim (2010) 0.97
Improved critical structure sparing with biologically based IMRT optimization. Med Phys (2009) 0.97
Statistical process control for IMRT dosimetric verification. Med Phys (2008) 0.97
Effect of breathing motion on radiotherapy dose accumulation in the abdomen using deformable registration. Int J Radiat Oncol Biol Phys (2010) 0.96
Robust optimization for intensity modulated radiation therapy treatment planning under uncertainty. Phys Med Biol (2005) 0.96
An on-line replanning method for head and neck adaptive radiotherapy. Med Phys (2009) 0.95
Automated registration of large deformations for adaptive radiation therapy of prostate cancer. Med Phys (2009) 0.94
Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: relationship to irradiated bone length, volume, tumor location and dose. Int J Radiat Oncol Biol Phys (2009) 0.94
An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor. Int J Radiat Oncol Biol Phys (2006) 0.94
Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. Med Phys (2003) 0.92
An on-line replanning scheme for interfractional variations. Med Phys (2008) 0.92
Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy. Int J Radiat Oncol Biol Phys (2012) 0.92
Equivalence of the linear-quadratic and two-lesion kinetic models. Phys Med Biol (2002) 0.92
Investigation of helical tomotherapy for partial-breast irradiation of prone-positioned patients. Int J Radiat Oncol Biol Phys (2009) 0.91
Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation. Int J Radiat Oncol Biol Phys (2008) 0.91
In vivo verification of superficial dose for head and neck treatments using intensity-modulated techniques. Med Phys (2009) 0.91
Evaluation of intrafraction patient movement for CNS and head & neck IMRT. Med Phys (2004) 0.91
Radiation planning comparison for superficial tissue avoidance in radiotherapy for soft tissue sarcoma of the lower extremity. Int J Radiat Oncol Biol Phys (2006) 0.91
Gated treatment delivery verification with on-line megavoltage fluoroscopy. Int J Radiat Oncol Biol Phys (2010) 0.89
Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys (2005) 0.89
Quality assessment of frameless fractionated stereotactic radiotherapy using cone beam computed tomography. Int J Radiat Oncol Biol Phys (2010) 0.89
Inter-society standards for the performance of brachytherapy: a joint report from ABS, ACMP and ACRO. Crit Rev Oncol Hematol (2003) 0.89